English  |  正體中文  |  简体中文  |  总笔数 :2826208  
造访人次 :  31898287    在线人数 :  1499
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"tsai m f"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 121-145 / 194 (共8页)
<< < 1 2 3 4 5 6 7 8 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2020-05-26T09:26:59Z Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations Chen Y.-F;Hsieh M.-S;Wu S.-G;Chang Y.-L;Shih J.-Y;Liu Y.-N;Tsai M.-F;Tsai T.-H;Yu C.-J;Chih-Hsin Yang;Yang P.-C.; Chen Y.-F; Hsieh M.-S; Wu S.-G; Chang Y.-L; Shih J.-Y; Liu Y.-N; Tsai M.-F; Tsai T.-H; Yu C.-J; CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏 2020-05-26T09:26:56Z IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer Shih J.-Y.;Chih-Hsin Yang;Yu S.-L;Chen H.-Y;Tsai T.-H;Wu S.-G;Tsai M.-F;Chang T.-H;Liu Y.-N; Liu Y.-N; Chang T.-H; Tsai M.-F; Wu S.-G; Tsai T.-H; Chen H.-Y; Yu S.-L; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏 2020-05-26T09:26:48Z The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients Shih J.-Y.;Wen Y.-F;Chih-Hsin Yang;Yang P.-C;Yu C.-J;Chang Y.-L;Tsai M.-F;Liu Y.-N;Wu S-G; Wu S-G; Liu Y.-N; Tsai M.-F; Chang Y.-L; Yu C.-J; Yang P.-C; CHIH-HSIN YANG; Wen Y.-F; Shih J.-Y.
臺大學術典藏 2020-05-04T07:55:42Z FRank: A ranking method with fidelity loss Tsai, M.-F.; Liu, T.-Y.; Qin, T.; Chen, H.-H.; Ma, W.-Y.; HSIN-HSI CHEN
臺大學術典藏 2020-03-26T06:54:27Z Transcription repressor Slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma Yang P.-C.; ANG YUAN; Yu C.-J.; Lin S.-B.; Liou G.-Y.; Lee M.-L.; Chen J.J.W.; Hong T.-M.; Yang S.-C.; Su J.-L.; Lee Y.-C.; Chang Y.-L.; Chang T.-H.; Tsai M.-F.; Shih J.-Y.; Shih J.-Y.;Tsai M.-F.;Chang T.-H.;Chang Y.-L.;Ang Yuan;Yu C.-J.;Lin S.-B.;Liou G.-Y.;Lee M.-L.;Chen J.J.W.;Hong T.-M.;Yang S.-C.;Su J.-L.;Lee Y.-C.;Yang P.-C.
臺大學術典藏 2020-03-07T06:56:55Z Transcription repressor Slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma Yuan A.; Yu C.-J.; Lin S.-B.; Liou G.-Y.; Lee M.-L.; Chen J.J.W.; Hong T.-M.; Yang S.-C.; Su J.-L.; Lee Y.-C.; Yang P.-C.; Shih J.-Y.;Tsai M.-F.;Chang T.-H.;Yih-Leong Chang;Yuan A.;Yu C.-J.;Lin S.-B.;Liou G.-Y.;Lee M.-L.;Chen J.J.W.;Hong T.-M.;Yang S.-C.;Su J.-L.;Lee Y.-C.;Yang P.-C.; Shih J.-Y.; Tsai M.-F.; Chang T.-H.; YIH-LEONG CHANG
臺大學術典藏 2020-03-07T06:56:54Z Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer Shih J.-Y.;Gow C.-H.;Yu C.-J.;Yang C.-H.;Yih-Leong Chang;Tsai M.-F.;Hsu Y.-C.;Chen K.-Y.;Su W.-P.;Yang P.-C.; Shih J.-Y.; Gow C.-H.; Yu C.-J.; Yang C.-H.; YIH-LEONG CHANG; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:43Z Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer Gow C.-H.; YIH-LEONG CHANG; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; Yu C.-J.; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-03-07T06:56:38Z Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction Wu S.-G. ;Yih-Leong Chang ;Lin J.-W. ;Wu C.-T. ;Chen H.-Y. ;Tsai M.-F. ;Lee Y.-C. ;Yu C.-J. ;Shih J.-Y.; Wu S.-G.; YIH-LEONG CHANG; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; Yu C.-J.; Shih J.-Y.
臺大學術典藏 2020-03-07T06:56:35Z EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR Wu S.-G.;Kuo Y.-W.;Yih-Leong Chang;Shih J.-Y.;Chen Y.-H.;Tsai M.-F.;Yu C.-J.;Yang C.-H.;Yang P.-C.; Wu S.-G.; Kuo Y.-W.; YIH-LEONG CHANG; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; Yu C.-J.; Yang C.-H.; Yang P.-C.
臺大學術典藏 2020-03-07T06:56:35Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Tsai T.-H.; Wu S.-G.; YIH-LEONG CHANG; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-03-07T06:56:27Z Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Yih-Leong Chang;Shih J.-Y.;Liu Y.-N.;Tsai M.-F.;Tsai T.-H.;Yu C.-J.;Yang J.C.-H.;Yang P.-C.; YIH-LEONG CHANG; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.
臺大學術典藏 2020-03-07T06:56:18Z The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients Wu S-G.; Liu Y.-N.; Tsai M.-F.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.
臺大學術典藏 2020-03-07T06:56:13Z Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y.; Chang T.-H.;Tsai M.-F.;Gow C.-H.;Wu S.-G.;Liu Y.-N.;Yih-Leong Chang;Yu S.-L.;Tsai H.-C.;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Shih J.-Y.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; YIH-LEONG CHANG; Yu S.-L.; Tsai H.-C.; Lin S.-W.
臺大學術典藏 2020-03-07T06:56:11Z IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; YIH-LEONG CHANG; Yu C.-J.; Shih J.-Y.; Wu S.-G.;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Yih-Leong Chang;Yu C.-J.;Shih J.-Y.; Wu S.-G.; Chang T.-H.
臺大學術典藏 2020-03-07T06:56:10Z Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tsai T.-H.;Gow C.-H.;Yih-Leong Chang;Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; Tsai T.-H.; Gow C.-H.; YIH-LEONG CHANG; Shih J.-Y.
臺大學術典藏 2020-03-06T05:26:40Z Transcription repressor Slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma Yang P.-C.; Lee Y.-C.; Su J.-L.; Yang S.-C.; Hong T.-M.; Chen J.J.W.; Lee M.-L.; Liou G.-Y.; Lin S.-B.; Shih J.-Y.; Tsai M.-F.; Chang T.-H.; YIH-LEONG CHANG; Yuan A.; Yu C.-J.
臺大學術典藏 2020-03-06T05:26:38Z Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer Shih J.-Y.; Gow C.-H.; Yu C.-J.; Yang C.-H.; YIH-LEONG CHANG; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C.
臺大學術典藏 2020-03-06T05:26:30Z Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern Wu S.-G.; YIH-LEONG CHANG; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2020-03-06T05:26:29Z Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer Gow C.-H.; YIH-LEONG CHANG; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; Yu C.-J.; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-03-06T05:26:24Z Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction Wu S.-G.; YIH-LEONG CHANG; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; Yu C.-J.; Shih J.-Y.
臺大學術典藏 2020-03-06T05:26:22Z EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR Tsai M.-F.; Yu C.-J.; Yang C.-H.; Yang P.-C.; Wu S.-G.; Kuo Y.-W.; YIH-LEONG CHANG; Shih J.-Y.; Chen Y.-H.
臺大學術典藏 2020-03-06T05:26:22Z Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma Tsai T.-H.; Wu S.-G.; YIH-LEONG CHANG; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2020-03-06T05:26:17Z Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; YIH-LEONG CHANG; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.
臺大學術典藏 2020-03-06T05:26:09Z The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients Wu S-G.; Liu Y.-N.; Tsai M.-F.; YIH-LEONG CHANG; Yu C.-J.; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.

显示项目 121-145 / 194 (共8页)
<< < 1 2 3 4 5 6 7 8 > >>
每页显示[10|25|50]项目